BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

439 related articles for article (PubMed ID: 15309910)

  • 1. Malignant progression in meningioma: documentation of a series and analysis of cytogenetic findings.
    Al-Mefty O; Kadri PA; Pravdenkova S; Sawyer JR; Stangeby C; Husain M
    J Neurosurg; 2004 Aug; 101(2):210-8. PubMed ID: 15309910
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Genetic changes with prognostic value in histologically benign meningiomas.
    Barbera S; San Miguel T; Gil-Benso R; Muñoz-Hidalgo L; Roldan P; Gonzalez-Darder J; Cerda-Nicolas M; Lopez-Gines C
    Clin Neuropathol; 2013; 32(4):311-7. PubMed ID: 23442303
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Intratumoral patterns of clonal evolution in meningiomas as defined by multicolor interphase fluorescence in situ hybridization (FISH): is there a relationship between histopathologically benign and atypical/anaplastic lesions?
    Sayagués JM; Tabernero MD; Maíllo A; Espinosa A; Rasillo A; Díaz P; Ciudad J; López A; Merino M; Gonçalves JM; Santos-Briz A; Morales F; Orfao A
    J Mol Diagn; 2004 Nov; 6(4):316-25. PubMed ID: 15507670
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Loss of material from chromosome arm 1p during malignant progression of meningioma revealed by fluorescent in situ hybridization.
    Ishino S; Hashimoto N; Fushiki S; Date K; Mori T; Fujimoto M; Nakagawa Y; Ueda S; Abe T; Inazawa J
    Cancer; 1998 Jul; 83(2):360-6. PubMed ID: 9669820
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Diagnostic and prognostic significance of genetic regional heterogeneity in meningiomas.
    Pfisterer WK; Hank NC; Preul MC; Hendricks WP; Pueschel J; Coons SW; Scheck AC
    Neuro Oncol; 2004 Oct; 6(4):290-9. PubMed ID: 15494096
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Evaluation of 1p and 14q status, MIB-1 labeling index and progesterone receptor immunoexpression in meningiomas: Adjuncts to histopathological grading and predictors of aggressive behavior.
    Kumar S; Kakkar A; Suri V; Kumar A; Bhagat U; Sharma MC; Singh M; Suri A; Sarkar C
    Neurol India; 2014; 62(4):376-82. PubMed ID: 25237942
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Meningioma: a model of cytogenetic evolution in tumoral initiation and progresion].
    López-Ginés C; Gil-Benso R; Collado-Díaz M; Gregori-Romero M; Roldán P; Barberá J; Cerdá-Nicolás M
    Neurocirugia (Astur); 2003 Dec; 14(6):517-25. PubMed ID: 14710307
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Application of oncogenetic trees mixtures as a biostatistical model of the clonal cytogenetic evolution of meningiomas.
    Ketter R; Urbschat S; Henn W; Feiden W; Beerenwinkel N; Lengauer T; Steudel WI; Zang KD; Rahnenführer J
    Int J Cancer; 2007 Oct; 121(7):1473-80. PubMed ID: 17557299
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Early recurrences in histologically benign/grade I meningiomas are associated with large tumors and coexistence of monosomy 14 and del(1p36) in the ancestral tumor cell clone.
    Maillo A; Orfao A; Espinosa AB; Sayagués JM; Merino M; Sousa P; Lara M; Tabernero MD
    Neuro Oncol; 2007 Oct; 9(4):438-46. PubMed ID: 17704362
    [TBL] [Abstract][Full Text] [Related]  

  • 10. NF2 gene mutations and allelic status of 1p, 14q and 22q in sporadic meningiomas.
    Leone PE; Bello MJ; de Campos JM; Vaquero J; Sarasa JL; Pestaña A; Rey JA
    Oncogene; 1999 Apr; 18(13):2231-9. PubMed ID: 10327069
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Progesterone and estrogen receptors: opposing prognostic indicators in meningiomas.
    Pravdenkova S; Al-Mefty O; Sawyer J; Husain M
    J Neurosurg; 2006 Aug; 105(2):163-73. PubMed ID: 17219818
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Allelic losses at 1p, 9q, 10q, 14q, and 22q in the progression of aggressive meningiomas and undifferentiated meningeal sarcomas.
    Lamszus K; Kluwe L; Matschke J; Meissner H; Laas R; Westphal M
    Cancer Genet Cytogenet; 1999 Apr; 110(2):103-10. PubMed ID: 10214357
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Detection of chromosome 1p deletion using FISH on meningioma touch imprints suggest a region outside chromosome 22 as important in tumor recurrence.
    Tamiolakis D; Papadopoulos N; Lambropoulou M; Kotini A; Simopoulos C
    Minerva Med; 2003 Feb; 94(1):51-6. PubMed ID: 12719702
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Chromosome 1p and 14q FISH analysis in clinicopathologic subsets of meningioma: diagnostic and prognostic implications.
    Cai DX; Banerjee R; Scheithauer BW; Lohse CM; Kleinschmidt-Demasters BK; Perry A
    J Neuropathol Exp Neurol; 2001 Jun; 60(6):628-36. PubMed ID: 11398839
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Predictive value of progression-associated chromosomal aberrations for the prognosis of meningiomas: a retrospective study of 198 cases.
    Ketter R; Henn W; Niedermayer I; Steilen-Gimbel H; König J; Zang KD; Steudel WI
    J Neurosurg; 2001 Oct; 95(4):601-7. PubMed ID: 11596954
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Her2neu amplification associates with Co-deletion 1p/14q in recurrent meningiomas.
    Hamilton BO; Sy JS; Megyesi JF; Ang LC
    Can J Neurol Sci; 2013 May; 40(3):361-5. PubMed ID: 23603172
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Histopathological and cytogenetic findings in benign, atypical and anaplastic human meningiomas: a study of 60 tumors.
    Cerdá-Nicolás M; López-Ginés C; Pérez-Bacete M; Barcia-Salorio JL; Llombart-Bosch A
    Clin Neuropathol; 2000; 19(6):259-67. PubMed ID: 11128617
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Radiation-associated meningiomas in children: clinical, pathological, and cytogenetic characteristics with a critical review of the literature.
    Elbabaa SK; Gokden M; Crawford JR; Kesari S; Saad AG
    J Neurosurg Pediatr; 2012 Oct; 10(4):281-90. PubMed ID: 22900483
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Multiple meningioma with different grades of malignancy: case report with genetic analysis applying single-nucleotide polymorphism array and classical cytogenetics.
    Mocker K; Holland H; Ahnert P; Schober R; Bauer M; Kirsten H; Koschny R; Meixensberger J; Krupp W
    Pathol Res Pract; 2011 Jan; 207(1):67-72. PubMed ID: 20926204
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Loss of 1p in recurrent meningiomas. a comparative study in successive recurrences by cytogenetics and fluorescence in situ hybridization.
    López-Ginés C; Cerdá-Nicolás M; Gil-Benso R; Barcia-Salorio JL; Llombart-Bosch A
    Cancer Genet Cytogenet; 2001 Mar; 125(2):119-24. PubMed ID: 11369054
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 22.